Early safety check: new Drug's impact on common meds
NCT ID NCT07444424
Summary
This early-stage study aims to understand how a new investigational drug, AZD5004, affects how the body processes two existing diabetes medications (mitiglinide and pioglitazone). It will involve 32 healthy volunteers to measure drug levels and check for safety. The goal is to gather basic information about potential drug interactions before testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Fukuoka, 813-0017, Japan
Conditions
Explore the condition pages connected to this study.